Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre
Clinical trials sponsored by Mcgill University Health Centre/research Institute Of The Mcgill University Health Centre, explained in plain language.
-
Trial halted early: testing a scarring drug for rare lung disease
Disease control TerminatedThis study aimed to see if adding the drug nintedanib to standard immune-suppressing medications was safe and tolerable for adults with myositis-related interstitial lung disease (MA-ILD), a condition where muscle inflammation causes progressive lung scarring. The goal was to slo…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Could umbilical cord cells save COVID patients from ventilators?
Disease control TerminatedThis study tested whether a single infusion of stem cells from umbilical cords could help hospitalized COVID-19 patients with severe pneumonia. The goal was to see if the treatment could prevent patients from needing a ventilator or dying. The trial was small, ended early, and co…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Tiny fentanyl dose tested to help COPD patients breathe easier
Symptom relief TerminatedThis study aimed to see if a very small dose of fentanyl, placed under the tongue, could help people with severe COPD breathe easier during exercise. It involved 40 patients who were already taking morphine for their breathlessness but still struggled. The trial was designed to c…
Phase: PHASE2, PHASE3 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC